Please use this identifier to cite or link to this item: 10.1002/gepi.22288
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFeng, Helian-
dc.contributor.authorGusev, Alexander-
dc.contributor.authorPasaniuc, Bogdan-
dc.contributor.authorGEMO Study Collaborators-
dc.contributor.authorNikitina-Zake, Liene-
dc.date.accessioned2022-01-17T11:30:01Z-
dc.date.available2022-01-17T11:30:01Z-
dc.date.issued2020-07-
dc.identifier.citationFeng , H , Gusev , A , Pasaniuc , B , GEMO Study Collaborators & Nikitina-Zake , L 2020 , ' Transcriptome-wide association study of breast cancer risk by estrogen-receptor status ' , Genetic Epidemiology , vol. 44 , no. 5 , pp. 442-468 . https://doi.org/10.1002/gepi.22288-
dc.identifier.issn0741-0395-
dc.identifier.otherunpaywall: 10.1002/gepi.22288-
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/7207-
dc.description© 2020 The Authors. Genetic Epidemiology published by Wiley Periodicals, Inc.-
dc.description.abstractPrevious transcriptome-wide association studies (TWAS) have identified breast cancer risk genes by integrating data from expression quantitative loci and genome-wide association studies (GWAS), but analyses of breast cancer subtype-specific associations have been limited. In this study, we conducted a TWAS using gene expression data from GTEx and summary statistics from the hitherto largest GWAS meta-analysis conducted for breast cancer overall, and by estrogen receptor subtypes (ER+ and ER-). We further compared associations with ER+ and ER- subtypes, using a case-only TWAS approach. We also conducted multigene conditional analyses in regions with multiple TWAS associations. Two genes, STXBP4 and HIST2H2BA, were specifically associated with ER+ but not with ER- breast cancer. We further identified 30 TWAS-significant genes associated with overall breast cancer risk, including four that were not identified in previous studies. Conditional analyses identified single independent breast-cancer gene in three of six regions harboring multiple TWAS-significant genes. Our study provides new information on breast cancer genetics and biology, particularly about genomic differences between ER+ and ER- breast cancer.en
dc.format.extent27-
dc.format.extent2563980-
dc.language.isoeng-
dc.relation.ispartofGenetic Epidemiology-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.subjectBreast Neoplasms/genetics-
dc.subjectEstrogens/metabolism-
dc.subjectFemale-
dc.subjectGenetic Predisposition to Disease-
dc.subjectGenome-Wide Association Study-
dc.subjectGenomics-
dc.subjectHumans-
dc.subjectReceptors, Estrogen/metabolism-
dc.subjectRisk Assessment-
dc.subjectTranscriptome-
dc.subjectVesicular Transport Proteins/genetics-
dc.subject1.6 Biological sciences-
dc.subject3.1 Basic medicine-
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database-
dc.subjectSDG 3 - Good Health and Well-being-
dc.titleTranscriptome-wide association study of breast cancer risk by estrogen-receptor statusen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article-
dc.identifier.doi10.1002/gepi.22288-
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85081379482&partnerID=8YFLogxK-
dc.description.statusPeer reviewed-
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.